<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-07T13:03:27Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/8768" metadataPrefix="rdf">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/8768</identifier><datestamp>2024-03-07T01:05:26Z</datestamp><setSpec>com_10259_4219</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>col_10259_4220</setSpec></header><metadata><rdf:RDF xmlns:rdf="http://www.openarchives.org/OAI/2.0/rdf/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:ow="http://www.ontoweb.org/ontology/1#" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
<ow:Publication rdf:about="oai:riubu.ubu.es:10259/8768">
<dc:title>Neuroimágenes sin evidencia de déficit dopaminérgico (SWEDD)</dc:title>
<dc:creator>Prieto Tedejo, Rosa</dc:creator>
<dc:creator>Velasco Palacios, Leticia</dc:creator>
<dc:creator>Jorge Roldán, Sandra</dc:creator>
<dc:creator>López Sárnago, P.</dc:creator>
<dc:creator>Cubo Delgado, Esther</dc:creator>
<dc:subject>DAT-SCAN</dc:subject>
<dc:subject>Enfermedad de Parkinson</dc:subject>
<dc:subject>Levodopa</dc:subject>
<dc:subject>SWEDDs</dc:subject>
<dc:subject>Temblor distónico</dc:subject>
<dc:subject>Temblor esencial</dc:subject>
<dc:subject>Parkinson’s disease</dc:subject>
<dc:subject>Levodopa</dc:subject>
<dc:subject>Dystonic tremor</dc:subject>
<dc:subject>Essential tremor</dc:subject>
<dc:description>Aproximadamente un 10% de los pacientes diagnosticados inicialmente de Enfermedad de Parkinson (E.P.), no presentan alteraciones en la vía dopaminérgica nigroestriatal en su vertiente presináptica; se engloban bajo el acrónimo SWEDDs (Scans without evidence of dopaminergic deficit).</dc:description>
<dc:description>Approximately 10% of all patients initially diagnosed with Parkinson's disease (PD) do not present any&#xd;
alterations in the presynaptic nigrostriatal dopaminergic pathway; they are classified under the acronym SWEDDs (Scans&#xd;
without evidence of dopaminergic deficit).</dc:description>
<dc:date>2024-03-06T13:24:35Z</dc:date>
<dc:date>2024-03-06T13:24:35Z</dc:date>
<dc:date>2012-10</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:identifier>0210-0010</dc:identifier>
<dc:identifier>http://hdl.handle.net/10259/8768</dc:identifier>
<dc:identifier>10.33588/rn.54S04.2012515</dc:identifier>
<dc:language>spa</dc:language>
<dc:relation>Revista de Neurología. 2012, V. 54, n. S04, p. 41-44</dc:relation>
<dc:relation>https://doi.org/10.33588/rn.54S04.2012515</dc:relation>
<dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 Internacional</dc:rights>
<dc:publisher>Viguera Editores</dc:publisher>
</ow:Publication>
</rdf:RDF></metadata></record></GetRecord></OAI-PMH>